AI Summary
Summary: Immunotherapy has shown promise in treating specific types of prostate cancer by slowing down disease progression in men with certain genetic characteristics. In a recent study, the progression of the disease was delayed by 33 months in these individuals.
New research has shown that immunotherapy can be effective in treating prostate cancer in men who are selected based on the genetic characteristics of their tumors. In a recent study, it was found that for some men with a particular genetic type of prostate cancer, the progression of the disease was slowed down by 33 months.